Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Eli Lilly and Co, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Eli Lilly and Co, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Eli Lilly and Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Eli Lilly and Co, Medical Equipment, Deal Details 12
Asset Purchase 12
Eli Lilly Acquires Rights to Intranasal Glucagon from Locemia Solutions 12
Eli Lilly Acquires Two Alzheimer’s Disease Imaging Agents From Siemens Medical Solutions 13
Venture Financing 14
EdiGene Raises USD15 Million in Pre-Series B Venture Financing 14
Rimidi Raises USD6.6 Million in Series A-1 Financing 15
Avedro Raises USD25 Million in Venture Financing 16
Veritas Genetics Raises USD30 Million in Series B Financing 18
Millin Enterprises Raises Funds through Series A financing 19
ACEA Biosciences Raises USD30 Million in Venture Financing 20
Microtech Medical Raises Funds through Series A Financing 21
Veritas Genetics Raises USD10 Million in Series A Financing Round 22
Companion Medical Raises USD3.15 Million in Series B Financing 23
Private Equity 24
Lilly Asia Ventures and HighLight Capital Invests USD77 Million in Sansure Biotech 24
Partnerships 25
Eli Lilly and Livongo Health Enter into Partnership 25
Eli Lilly and Co Enters into Co-Development Agreement with Rimidi Diabetes 26
DexCom Enters into Agreement with Eli Lilly 27
Insulet Enters into Co-Development Agreement with Eli Lilly 28
Qiagen Enters into Co-Development Agreement with Eli Lilly for Companion Diagnostic Test 29
Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test 30
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 31
Corgenix Enters Into Co-Development Agreement With Eli Lilly 32
Insulet Enters Into Co-Development Agreement With Eli Lilly 33
Qiagen Enters Into Co-Development Agreement With Eli Lilly 34
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 35
PrimeraDx Enters Into Co-Development Agreement With Eli Lilly 36
Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid 37
Eli Lilly Enters into Licensing Agreement with Transcriptic 38
Equity Offering 39
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 39
Eli Lilly and Co – Key Competitors 41
Eli Lilly and Co – Key Employees 42
Eli Lilly and Co – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 52
Recent Developments 53
Strategy And Business Planning 53
Sep 07, 2017: Lilly Takes Steps To Streamline Business, Invest In New Medicines And Drive Growth 53
Financial Announcements 54
Jul 24, 2018: Lilly Delivers Strong Second-Quarter 2018 Results, Revises EPS Guidance 54
Apr 24, 2018: Lilly Reports First-Quarter 2018 Financial Results 57
Jan 31, 2018: Lilly Reports Strong Fourth-Quarter and Full-Year 2017 Revenue Growth, Increases 2018 EPS Guidance 62
Dec 13, 2017: Lilly Announces 2018 Financial Guidance and Enhances Outlook Through 2020 68
Oct 24, 2017: Lilly Reports Third-Quarter Results 2017 69
Jul 25, 2017: Lilly Reports Second-Quarter Results 74
Apr 25, 2017: Lilly Reports First-Quarter 2017 Results 78
Jan 31, 2017: Lilly Reports Fourth-Quarter And Full-Year 2016 Results 82
Corporate Communications 88
May 23, 2018: Eli Lilly and Company Announces Retirement Of Sue Mahony As President Of Lilly Oncology 88
Mar 09, 2018: Maura Dickler, M.D. To Become Vice President Of Late Phase Development At Lilly Oncology 89
Dec 11, 2017: Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology 90
Nov 13, 2017: Lilly Appoints Philip Johnson to Senior Vice President and Treasurer 91
Sep 29, 2017: Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing 92
Jun 01, 2017: Derica Rice To Retire As Lilly Chief Financial Officer 93
May 10, 2017: Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications 94
Mar 02, 2017: Lilly Announces Changes In Senior Management 95
Feb 09, 2017: Carolyn R. Bertozzi, Ph.D., Elected To Lilly Board Of Directors 96
Legal and Regulatory 97
Aug 30, 2018: Adocia announces update to second arbitration against Eli Lilly & Company 97
Government and Public Interest 98
Apr 04, 2017: Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for Medical Students 98
Other Significant Developments 99
Sep 25, 2017: Geisinger And Boehringer Ingelheim Collaborate To Create A Predictive Model To Help Improve Health Outcomes For People With Type 2 Diabetes 99
Jun 21, 2017: Eli Lilly And Company Unveils Expanded Biotechnology Center In San Diego 100
May 17, 2017: Cogstate Selected as Preferred Provider to Lilly’s Alzheimer’s Disease Platform 101
Jan 05, 2017: Lilly To Adjust Organization And Leadership Structure To Better Align With Growth Opportunities 102
Appendix 103
Methodology 103
About GlobalData 103
Contact Us 103
Disclaimer 103
Eli Lilly and Co, Medical Equipment, Key Facts, 2017 2
Eli Lilly and Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Eli Lilly and Co, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Eli Lilly and Co, Deals By Market, 2012 to YTD 2018 9
Eli Lilly and Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Eli Lilly Acquires Rights to Intranasal Glucagon from Locemia Solutions 12
Eli Lilly Acquires Two Alzheimer's Disease Imaging Agents From Siemens Medical Solutions 13
EdiGene Raises USD15 Million in Pre-Series B Venture Financing 14
Rimidi Raises USD6.6 Million in Series A-1 Financing 15
Avedro Raises USD25 Million in Venture Financing 16
Veritas Genetics Raises USD30 Million in Series B Financing 18
Millin Enterprises Raises Funds through Series A financing 19
ACEA Biosciences Raises USD30 Million in Venture Financing 20
Microtech Medical Raises Funds through Series A Financing 21
Veritas Genetics Raises USD10 Million in Series A Financing Round 22
Companion Medical Raises USD3.15 Million in Series B Financing 23
Lilly Asia Ventures and HighLight Capital Invests USD77 Million in Sansure Biotech 24
Eli Lilly and Livongo Health Enter into Partnership 25
Eli Lilly and Co Enters into Co-Development Agreement with Rimidi Diabetes 26
DexCom Enters into Agreement with Eli Lilly 27
Insulet Enters into Co-Development Agreement with Eli Lilly 28
Qiagen Enters into Co-Development Agreement with Eli Lilly for Companion Diagnostic Test 29
Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test 30
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 31
Corgenix Enters Into Co-Development Agreement With Eli Lilly 32
Insulet Enters Into Co-Development Agreement With Eli Lilly 33
Qiagen Enters Into Co-Development Agreement With Eli Lilly 34
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 35
PrimeraDx Enters Into Co-Development Agreement With Eli Lilly 36
Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid 37
Eli Lilly Enters into Licensing Agreement with Transcriptic 38
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 39
Eli Lilly and Co, Key Competitors 41
Eli Lilly and Co, Key Employees 42
Eli Lilly and Co, Subsidiaries 44
Eli Lilly and Co, Joint Venture 52
List of Figures
Eli Lilly and Co, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Eli Lilly and Co, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Eli Lilly and Co, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Eli Lilly and Co, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
【免責事項】
http://www.globalresearch.jp/disclaimer